US Equities Analysis

CRL — Charles River Laboratories

Research evidence pack

Source-backed valuation visuals

Loading verified snapshot
Loading verified market, valuation, and statement data.

2. Company Fundamentals

2.1 Competitiveness

Metric Value
Operating Margins 15.92%
Profit Margins -4.58%
Return on Equity -5.87%
Return on Assets 4.26%
Free Float 0.05B
Short Int % Utilisation 9.34%

2.2 Growth

Metric Value
Revenue Growth 1.2%
Free Cash Flow 0.51B
EBITDA 13.37 (Ratio)
Enterprise Value 11.89B
EV/Revenue 2.95
EV/EBITDA 13.37

Revenue growth of 1.2% suggests mature or challenged top-line momentum.

2.3 Management

Role Metric
Consensus Rating N/A

2.4 Return

Metric Value
Expected Return (Ann.)* 99.25%
Risk / Std Dev (Ann.)* 45.86%
1-Year Price Return* 78.74%

Latest Market Data (as of 2026-08-14, US Eastern time):

Metric Value
Last Price $280.05
52-Week Range $144.26 – $288.02
Observation Count 251 trading days

The return and risk statistics use daily adjusted closes from the retrieved one-year series and annualise daily moments using 252 trading days. The last price is the latest regular-market price reported for the stated date. Source: Yahoo Finance market data.

2.5 Valuation & Cash Flow

Valuation basis: The operating-company framework starts with reported EBIT, taxes, non-cash charges, capital expenditure and working-capital movement to derive unlevered free cash flow. It is a current-input research view, not an intrinsic-value target price because a sourced forecast and peer-beta workstream are still required.

Valuation input Value
Last market price $286.64
Market capitalisation $13.68B
Enterprise value proxy $16.04B
Revenue $4.02B
EBIT $7.53M
EBITDA $410.84M
Reported free cash flow $518.49M
Unlevered free cash flow $204.19M
FCF yield 3.79%
EV / EBITDA proxy 39.04x
Net debt / EBITDA 5.74x

WACC Workbench

WACC input Value
Risk-free rate 4.72%
Equity risk premium assumption 5.50%
Beta 1.38
Cost of equity 12.29%
Pre-tax cost of debt 4.04%
WACC 10.85%
WACC validation within standard range

2.6 Investor-Style Research Screen

Educational screen Result
Buffett-inspired cash-quality checks 3/4 evidenced checks
Lynch-inspired balance-and-growth checks 3/4 evidenced checks

Data lineage: Yahoo Finance public market and statement data; retrieval timestamp: 2026-08-17 23:32:16.519578 UTC; latest reported fiscal period: 2025-12-31 00:00:00. WACC uses a live 10-year Treasury proxy when available, a 5.50% ERP assumption, reported beta where available, and an interest-expense / average-debt proxy for cost of debt. This is research and analysis only, not personalized financial advice.

us-equity stock equity crl health-care life-sciences-tools--services nasdaq